Barkhof F - Search Results

1

Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.

Ten Kate M, Barkhof F, Boccardi M, Visser PJ, Jack CR Jr, Lovblad KO, Frisoni GB, Scheltens P; Geneva Task Force for the Roadmap of Alzheimer's Biomarkers. Ten Kate M, et al. Among authors: barkhof f. Neurobiol Aging. 2017 Apr;52:167-182.e1. doi: 10.1016/j.neurobiolaging.2016.05.024. Neurobiol Aging. 2017. PMID: 28317647 Review.

2

A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone.

Barkhof F, Frequin ST, Hommes OR, Lamers K, Scheltens P, van Geel WJ, Valk J. Barkhof F, et al. Neurology. 1992 Jan;42(1):63-7. doi: 10.1212/wnl.42.1.63. Neurology. 1992. PMID: 1370864

3

Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.

Barkhof F, Scheltens P, Frequin ST, Nauta JJ, Tas MW, Valk J, Hommes OR. Barkhof F, et al. AJR Am J Roentgenol. 1992 Nov;159(5):1041-7. doi: 10.2214/ajr.159.5.1414773. AJR Am J Roentgenol. 1992. PMID: 1414773

4

Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J. Scheltens P, et al. Among authors: barkhof f. J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):967-72. doi: 10.1136/jnnp.55.10.967. J Neurol Neurosurg Psychiatry. 1992. PMID: 1431963 Free PMC article.

5

Meningeal Gd-DTPA enhancement in multiple sclerosis.

Barkhof F, Valk J, Hommes OR, Scheltens P. Barkhof F, et al. AJNR Am J Neuroradiol. 1992 Jan-Feb;13(1):397-400. AJNR Am J Neuroradiol. 1992. PMID: 1595484 Free PMC article. No abstract available.

6

White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity.

Scheltens P, Barkhof F, Valk J, Algra PR, van der Hoop RG, Nauta J, Wolters EC. Scheltens P, et al. Among authors: barkhof f. Brain. 1992 Jun;115 ( Pt 3):735-48. doi: 10.1093/brain/115.3.735. Brain. 1992. PMID: 1628199

7

Gadopentetate dimeglumine enhancement of multiple sclerosis lesions on long TR spin-echo images at 0.6 T.

Barkhof F, Valk J, Hommes OR, Scheltens P, Nauta JJ. Barkhof F, et al. AJNR Am J Neuroradiol. 1992 Jul-Aug;13(4):1257-9. AJNR Am J Neuroradiol. 1992. PMID: 1636547 Free PMC article.

8

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis.

Barkhof F, Hommes OR, Scheltens P, Valk J. Barkhof F, et al. Neurology. 1991 Aug;41(8):1219-22. doi: 10.1212/wnl.41.8.1219. Neurology. 1991. PMID: 1866009

9

Serial quantitative MR assessment of optic neuritis in a case of neuromyelitis optica, using Gadolinium- "enhanced" STIR imaging.

Barkhof F, Scheltens P, Valk J, Waalewijn C, Uitdehaag BM, Polman CH. Barkhof F, et al. Neuroradiology. 1991;33(1):70-1. doi: 10.1007/BF00593340. Neuroradiology. 1991. PMID: 2027451

10

[Vascular dementia].

Scheltens P, Barkhof F, Valk J, Wolters EC. Scheltens P, et al. Among authors: barkhof f. Ned Tijdschr Geneeskd. 1990 May 19;134(20):1018-9. Ned Tijdschr Geneeskd. 1990. PMID: 2348894 Dutch. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,452 results

Search Page